NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
Tabletop particle accelerator could transform medicine and materials science 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug 
Since its outbreak in December of 2019, the COVID-19 pandemic has affected millions of people all over the world. As cases of the coronavirus rise in many countries, scientists have shown images happening in real-time on how the virus attacks the cells in the human body.
Express reports real-time images were shown of how the coronavirus SARS-CoV2 attacks humans. From the images, it shows a spike protein on the coronavirus functioning as the main weapon to mobilize the DNA into a host cell. The virus then attacks and sticks into the ACE 2 enzyme, becoming an important process in how the virus is spread. The ACE 2 enzyme receptors are what enable the attack by the virus.
Scientists from the Naval Research Laboratory, the team of Kiril Gorshkov and Eunkeu Oh were able to image this process. They also used this same imaging process for cancers, lysosomal storage diseases, and other viral diseases. “You can actually see that happen in real-time. That’s the beauty of this essay and that’s why we think it will be important for drug screening,” said Dr. Gorshkov.
As the months go by, scientists are scrambling to speed up research and develop a vaccine that could help treat COVID-19 patients and prevent others from contracting the virus. As a result, to at least slow down the spread, social distancing practices and quarantine periods are put in place by the respective governments in countries that are affected. Face masks are also required to be worn in places where social distancing could not be maintained.
Schools have also resorted to online or remote learning but there are some educational institutions that have reopened to allow for in-person learning. However, as there are several months left until the Christmas season, an expert has warned not to anticipate that a vaccine would be available by that time.
UK Health Secretary Matt Hancock commented on what is known as the Oxford vaccine, that is produced by the UK pharmaceutical firm AstraZenica and is currently on its phase three trials with over 50,000 volunteers spanning in different countries. “The best-case scenario is that happens this year. I think more likely is the early part of next year -- in the first few months of next year is the most likely,” said Hancock.
